Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy (clinicaltrials.gov) - Oct 3, 2026 - P2 | N=15 | Completed | Sponsor: Emory University | Active, not recruiting ➔ Completed
Checkpoint inhibition • Trial completion • Cutaneous Melanoma • Melanoma • Oncology • Solid Tumor
|